Anthony M. Nicasio

Population Pharmacokinetics of High-Dose, Prolonged-Infusion Cefepime in Adult Critically Ill Patients with Ventilator-Associated Pneumonia

Anthony M. Nicasio, Robert E. Ariano, Sheryl Zelenitsky et al. · Antimicrobial Agents and Chemotherapy · 2009 · 119 citations · Full text

Nephrology, Population Pharmacokinetics, Physiologically-based Pharmacokinetic Modeling +17

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an <i>In Vitro</i> Infection Model

Brian VanScoy, Rodrigo E. Mendes, Anthony M. Nicasio et al. · Antimicrobial Agents and Chemotherapy · 2013 · 105 citations · Full text

Optimization of meropenem dosage in the critically ill population based on renal function

Jared L. Crandon, Robert E. Ariano, Sheryl Zelenitsky et al. · Intensive Care Medicine · 2010 · 98 citations · Full text

Hypertension, Hemodialysis, Renal Function +9

Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia

Anthony M. Nicasio, Kathryn J. Eagye, David P. Nicolau et al. · Journal of Critical Care · 2009 · 87 citations

Empiric Antibiotic Choice, Antibiotics, Pharmacodynamic-based Clinical Pathway +9

Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival

Nathaniel J. Rhodes, Joseph L. Kuti, David P. Nicolau et al. · Antimicrobial Agents and Chemotherapy · 2015 · 59 citations · Full text

Improved Survival, Logistic Analysis, Drug Resistance +20